Thank you very much, Drakemaster, for not only working out what had happened , but especially for taking so much trouble to explain it to the rest of us
On Polynovo, which I mentioned in another thread (which I think existed under another name before relisting in 2015) - I meant that most very small companies - biotech or junior mining explorers - rely on frequent cap raises for years while they develop the products/ explore. Actually, on reflection, I decided that Osteopore was different - it had products, and needed capital to expand into new markets, and so on.
Agree - this morning's announcement was positive. Now a nervous wait to see whether the sales people are assertive enough, but especially whether the products are good enough (in fact, superior enough), to capture market share. All the best, Mirri
OSX Price at posting:
8.0¢ Sentiment: Hold Disclosure: Held
